13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Translational Neurology
Translational neurology bridges the gap between laboratory research and clinical application, accelerating advancements in neurological care. By transforming fundamental discoveries into practical treatments, this field addresses unmet medical needs in conditions such as Parkinson’s disease, Alzheimer’s, and spinal cord injuries. Translational Neurology emphasizes the importance of preclinical studies in developing targeted therapies, ensuring their efficacy and safety before clinical trials. Emerging technologies like gene editing and stem cell therapy are pivotal in shaping innovative approaches for neurological repair and regeneration. Collaborative efforts between researchers and clinicians foster real-world applications, ultimately enhancing patient outcomes and paving the way for groundbreaking interventions.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Ananya Rajasekaran, ThinkNeuro, United States